Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44+CD133+ subpopulation of Caco-2 cells

Int J Biol Sci. 2021 Apr 12;17(7):1644-1659. doi: 10.7150/ijbs.58612. eCollection 2021.

Abstract

Tumor-initiating cells or cancer stem cells are a subset of cancer cells that have tumorigenic potential in human cancer. Although several markers have been proposed to distinguish tumor-initiating cells from colorectal cancer cells, little is known about how this subpopulation contributes to tumorigenesis. Here, we characterized a tumor-initiating cell subpopulation from Caco-2 colorectal cancer cells. Based on the findings that Caco-2 cell subpopulations express different cell surface markers, we were able to discriminate three main fractions, CD44-CD133-, CD44-CD133+, and CD44+CD133+ subsets, and characterized their biochemical and tumorigenic properties. Our results show that CD44+CD133+ cells possessed an unusual capacity to proliferate and could form tumors when transplanted into NSG mice. Additionally, primary tumors grown from CD44+CD133+ Caco-2 cells contained mixed populations of CD44+CD133+ and non-CD44+CD133+ Caco-2 cells, indicating that the full phenotypic heterogeneity of the parental Caco-2 cells was re-created. Notably, only the CD44+CD133+ subset of Caco-2-derived primary tumors had tumorigenic potential in NSG mice, and the tumor growth of CD44+CD133+ cells was faster in secondary xenografts than in primary transplants. Gene expression analysis revealed that the Wnt/β-catenin pathway was over-activated in CD44+CD133+ cells, and the growth and tumorigenic potential of this subpopulation were significantly suppressed by small-molecule Wnt/β-catenin signaling inhibitors. Our findings suggest that the CD44+CD133+ subpopulation from Caco-2 cells was highly enriched in tumorigenic cells and will be useful for investigating the mechanisms leading to human colorectal cancer development.

Keywords: CD133; CD44; Caco-2; IWR-1; Tumor-initiating cells; Tumorigenic potential; Wnt/β-catenin signaling inhibitor; XAV939.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen / biosynthesis
  • AC133 Antigen / genetics*
  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / genetics
  • Caco-2 Cells
  • Carcinogenesis / genetics*
  • Cell Transformation, Neoplastic
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Hyaluronan Receptors / biosynthesis
  • Hyaluronan Receptors / genetics*
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Wnt Signaling Pathway / genetics*
  • beta Catenin / biosynthesis
  • beta Catenin / genetics*

Substances

  • AC133 Antigen
  • Biomarkers, Tumor
  • CD44 protein, human
  • Hyaluronan Receptors
  • PROM1 protein, human
  • beta Catenin